UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Daewoong promotes botulinum toxin Nabota in Dubai
Daewoong Pharmaceutical has begun pushing international marketing activitie...
by So Jae-hyeon
|
2018-03-21 15:47
라인
Seoul to punish drugmakers for offering rebates via outsourced firms
The government has toughened up regulations on outsourced pharmaceutical co...
by So Jae-hyeon
|
2018-03-20 16:30
라인
World’s top painkiller Advil underperforms in Korea
Advil, the world’s best-selling pain reliever, is not performing well in Ko...
by So Jae-hyeon
|
2018-03-20 11:16
라인
Godex tops prescription liver drug in sales
Celltrion Pharm’s Godex, a prescription treatment for liver disease, won th...
by So Jae-hyeon
|
2018-03-19 15:47
라인
Will SK Chemicals get more reimbursement for Parkinson’s disease drug?
Whether SK Chemicals will get expanded insurance coverage for its newly imp...
by So Jae-hyeon
|
2018-03-19 14:24
라인
Seoul's antismoking policy mainly benefits multinational pharma firms
Multinational pharmaceutical companies benefited from the Korean government...
by So Jae-hyeon
|
2018-03-15 15:47
라인
Drugmakers shift PR focus to corporate brand
Local drugmakers and biotech companies started to shift the focus of public...
by So Jae-hyeon
|
2018-03-14 16:02
라인
Multinationals cause drug shortages -- again
Multinational drugmakers are repeatedly causing drug shortages every year i...
by So Jae-hyeon
|
2018-03-14 12:46
라인
MSD, SK Chemicals engage in shingles vaccine war
The competition between MSD Korea and SK Chemicals is heating up over the d...
by So Jae-hyeon
|
2018-03-13 14:38
라인
Drugmakers to unveil cancer studies in US, UK in April
Korean drugmakers are eyeing opportunities to enlarge their overseas market...
by So Jae-hyeon
|
2018-03-12 16:10
라인
Sales of popular OTC drugs up 5.5% last year
Local drugmakers benefited from steady sales growth of popular over-the-cou...
by So Jae-hyeon
|
2018-03-12 13:52
라인
Korean drugmakers continue Botox war in US, China
The severe domestic competition among three drugmakers over Botulinum toxin...
by So Jae-hyeon
|
2018-03-07 16:04
라인
Celltrion’s Remsima tops local biosimilar market
Celltrion’s Remsima topped the sales among the five local biosimilar produc...
by So Jae-hyeon
|
2018-03-07 14:59
라인
Pharma industry group to support AI-based new drugs
Korea’s largest group of pharmaceutical companies said it would develop an ...
by So Jae-hyeon
|
2018-03-06 14:47
라인
Multinationals led drug sales in Korea in 2017
Multinational pharmaceutical companies led the local sales of medicine in K...
by So Jae-hyeon
|
2018-03-06 11:38
라인
Small biotech firms lead filing drug patents
Small and medium-sized pharmaceutical and biotech companies are actively fi...
by So Jae-hyeon
|
2018-03-05 15:33
라인
‘Upcoming dementia generics might not succeed’
With the government’s push to enhance the state’s role to fight dementia, l...
by So Jae-hyeon
|
2018-02-27 16:30
라인
Local drugmakers shift focus to convenient drugs
Local drugmakers are diversifying their strategies into developing novel dr...
by So Jae-hyeon
|
2018-02-27 14:26
라인
Han Wha Pharma to sell allergen blocker cream
Han Wha Pharma said recently it would start selling Rhino-Protect PRS, a na...
by So Jae-hyeon
|
2018-02-26 15:46
라인
Seoul to help drugmakers’ advance overseas
The government said it would fully support local drugmakers seeking to expa...
by So Jae-hyeon
|
2018-02-26 15:25
-
1
2
3
4
5
6
7
8
9
10
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top